Published in J Neuroendocrinol on August 01, 2002
Nonmammalian gonadotropin-releasing hormone molecules in the brain of promoter transgenic rats. Proc Natl Acad Sci U S A (2005) 0.78
Protein expression profile of HT-29 human colon cancer cells after treatment with a cytotoxic daunorubicin-GnRH-III derivative bioconjugate. PLoS One (2014) 0.75
Angiography-proven liver metastases explain low efficacy of lymph node dissections in medullary thyroid cancer patients. Eur J Surg Oncol (2005) 1.41
Synthesis and biological evaluation of superactive agonists of growth hormone-releasing hormone. Proc Natl Acad Sci U S A (1995) 1.27
Synthesis and biological activities of highly potent antagonists of growth hormone-releasing hormone. Proc Natl Acad Sci U S A (1994) 1.19
Synthesis and in vitro evaluation of new potent antagonists of growth hormone-releasing hormone (GH-RH). Peptides (1997) 1.06
Combined retrograde tracing and immunocytochemical identification of luteinizing hormone-releasing hormone- and somatostatin-containing neurons projecting to the median eminence of the rat. Endocrinology (1989) 0.93
Branched-chain analogues of luteinizing hormone-releasing hormone. J Med Chem (1978) 0.90
Establishment, characterization and drug sensitivity of a new anaplastic thyroid carcinoma cell line (BHT-101). Virchows Arch B Cell Pathol Incl Mol Pathol (1993) 0.90
Recovery of pituitary function after treatment with a targeted cytotoxic analog of luteinizing hormone-releasing hormone. Proc Natl Acad Sci U S A (1997) 0.89
Some possible dynamical constraints for life's origin. Orig Life Evol Biosph (2009) 0.87
Luteinizing hormone-releasing hormone analogs with increased anti-ovulatory activity. Biochem Biophys Res Commun (1981) 0.85
Direct anticancer activity of gonadotropin-releasing hormone-III. J Pept Res (1998) 0.82
Effect of gonadotropin-releasing hormone analogs and their conjugates on gonadotropin-releasing hormone receptor--positive human cancer cell lines. Cancer Detect Prev (1996) 0.82
Biological evolution of replicator systems: towards a quantitative approach. Orig Life Evol Biosph (2013) 0.81
Inhibition of the UCI-107 human ovarian carcinoma cell line by a targeted cytotoxic analog of somatostatin, AN-238. Cancer (2001) 0.81
A single in vivo administration of bombesin antagonist RC-3095 reduces the levels and mRNA expression of epidermal growth factor receptors in MXT mouse mammary cancers. Proc Natl Acad Sci U S A (1997) 0.81
Synthesis and biological activity of LH-RH antagonists modified in position 1. Peptides (1983) 0.80
Liquid chromatographic and mass spectrometric analysis of human serum acid alpha-1-glycoprotein. Biomed Chromatogr (2004) 0.80
Pelvic pain in endometriosis: painkillers or sport to alleviate symptoms? Acta Physiol Hung (2010) 0.79
Cyclic analogues of luteinizing hormone-releasing hormone with significant biological activities. J Med Chem (1978) 0.78
FDG PET imaging in hereditary thyroid cancer. Eur J Surg Oncol (2003) 0.78
Synthesis of gonadotropin-releasing hormone III analogs. Structure-antitumor activity relationships. J Med Chem (1997) 0.78
In the central role of GnRH in the regulation of reproductive functions: mechanism of action and practical results. J Steroid Biochem (1985) 0.78
Gonadotropin-releasing hormone analogue conjugates with strong selective antitumor activity. Proc Natl Acad Sci U S A (1999) 0.78
Changes in the expression of pituitary adenylate cyclase-activating polypeptide in the human placenta during pregnancy and its effects on the survival of JAR choriocarcinoma cells. J Mol Neurosci (2010) 0.78
Identification of a bovine beta-mannosidosis mutation and detection of two beta-mannosidase pseudogenes. Mamm Genome (1999) 0.78
Distribution of 3H-alpha-MSH in rat brain. Brain Res Bull (1977) 0.78
Synthesis of GnRH analogs having direct antitumor and low LH-releasing activity. Biomed Pept Proteins Nucleic Acids (1996) 0.77
Long-term inhibition of ovulation by a GnRH-antagonist at low dose level. Biochem Biophys Res Commun (1984) 0.77
The Pro-LHRH system of the rat brain. Effects of changes in the endocrine background. Brain Res Bull (1988) 0.77
Hormonal effects of toremifene in breast cancer patients. J Steroid Biochem (1990) 0.76
Investigation of pituitary adenylate cyclase activating polypeptide in human gynecological and other biological fluids by using MALDI TOF mass spectrometry. J Mass Spectrom (2011) 0.76
Results with colposuspension by the Burch procedure in our practice. Am J Obstet Gynecol (2002) 0.75
Postoperative thyroglobulin level determination to follow up patients with highly differentiated thyroid cancer. Oncology (1989) 0.75
Decreased in vitro LH releasing activity of oligomeric LH-RH derivatives. Endocrinol Exp (1984) 0.75
[Follow up of thyroglobulin levels in patients with surgically treated, highly differentiated thyroid cancer]. Orv Hetil (1989) 0.75
Hormonal changes during a prolonged tamoxifen treatment in patients with advanced breast cancer. Oncology (1986) 0.75
Action of inhibitory LH-RH analogs in rat pituitary and luteal cell cultures. Endocrinol Exp (1984) 0.75
Preparation and characterization of photoreactive derivatives of GnRH. Persistent activation of function by photoaffinity labeling. Int J Pept Protein Res (1984) 0.75
Influence of antiestrogen drugs on the sex hormone and sex hormone-binding globulin levels in breast cancer patients. Ann N Y Acad Sci (1988) 0.75
Increase in mRNA concentrations of pituitary receptors for growth hormone-releasing hormone and growth hormone secretagogues after neonatal monosodium glutamate treatment. J Neuroendocrinol (2000) 0.75
[Significance of estradiol-progesterone levels in breast tissue in the management of breast cancer]. Orv Hetil (1983) 0.75
[Study of antibacterial properties of alpha-alkylserines and 4-alkyl substituted derivatives of cycloserine]. Antibiotiki (1968) 0.75
[The anti-estrogenic effect of 4-chloro-1,2-diphenyl-1-(4-[2-(N,N-dimethylamino)ethoxy]phenyl)1-butene (Toremifene) on the endocrine regulation in breast cancer patients]. Orv Hetil (1991) 0.75
[Screening of families of patients with medullary cancer of the thyroid]. Orv Hetil (1982) 0.75
Effects of pituitary adenylate cyclase activating polypeptide on human sperm motility. J Mol Neurosci (2012) 0.75
[Clinical significance of steroid receptors in breast cancer]. Orv Hetil (1994) 0.75
Influence on antiproliferative activity of structural modification and conjugation of gonadotropin-releasing hormone (GnRH) analogues. Cell Prolif (2000) 0.75
Influence of toremifene on the endocrine regulation in breast cancer patients. Eur J Cancer (1994) 0.75
Comparative studies on the polyamine metabolism and DFMO treatment of MCF-7 and MDA-MB-231 breast cancer cell lines and xenografts. Anticancer Res (1992) 0.75
Ovulation induced by autologous pituitary extracts in androgen and light-sterilized rats. Arch Anat Histol Embryol (1968) 0.75
Synthesis, conformation, biodistribution, and hormone-related in vitro antitumor activity of a gonadotropin-releasing hormone antagonist-branched polypeptide conjugate. Bioconjug Chem (1997) 0.75
The phosphorylation site of Ca(2+)-dependent protein kinase from alfalfa. Plant Mol Biol (1989) 0.75
[Trends in the hormonal therapy of thyroid cancer]. Orv Hetil (1989) 0.75
The treatment planning system at work. A case in point. Dent Clin North Am (1976) 0.75